Innovative Therapies Hold Great Promise & New Challenges

Experience: Immunotherapy

Innovative Therapies Hold Great Promise & New Challenges

Experience: Immunotherapy

Stem cell, gene therapy, mAbs, oncolytic viruses—immunotherapy holds great promise for innovative, less-invasive treatments to fight disease, with significant progress already made. But cell and gene therapies often pose challenges in patient screening, logistics and regulatory processes. 

An important, yet difficult, aspect of ensuring success in these trials is the ability to anticipate challenges before they happen. Innovative biopharma companies need to work with a CRO that understands the special considerations of drug trials in immunotherapy—including challenges around patient screening and selection, intricate trial logistics and complex global regulatory requirements--and that has the flexibility and attention to work with them closely throughout the process.

With more than 10 years’ experience managing immunotherapy trials across multiple indications, including allergy, cardiovascular, oncology, ophthalmology, and more, SynteractHCR has the expertise that sponsors need to handle the unique challenges these trials hold.

Immunotherapy Infographic

Well-rounded experience

SynteractHCR has conducted immunotherapy trials in several therapeutic areas, including oncology, vaccines, allergy, arthritis and others. You can be confident that we can help you to meet the challenges head-on.

Get in Touch

Global Headquarters:
5909 Sea Otter Place
Carlsbad, CA 92010

Phone: +1 760 268 8200
Fax: +1 760 929 1419

x

Contact SynteractHCR

Tell us how to stay in touch with you:


Required(*)
Cancel